<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03295903</url>
  </required_header>
  <id_info>
    <org_study_id>H17-01957</org_study_id>
    <nct_id>NCT03295903</nct_id>
  </id_info>
  <brief_title>Cannabinoid Supplementation on Vascular and Cognitive Function</brief_title>
  <official_title>The Effects of Cannabinoids on Vascular and Cognitive Function in Young and Old Healthy Adults.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lexaria Bioscoence Corp</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mitacs</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cannabidiol (CBD) is a bioactive cannabinoid compound in marijuana (cannabis sativa), but
      unlike Î”9 tetrahydrocannabinol (THC), lacks the psychoactivity effect of THC. Available
      evidence suggests that there are marked therapeutic CBD effects for diverse disease processes
      including inflammation, cancers, psychosis, and epileptic seizures. The purpose of this
      study, in both younger and older healthy humans, is to improve our understanding of how CBD
      might control and regulate blood vessel health as well as cognitive and exercise performance.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2017</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Circulating cannabidiol and nitric oxide markers</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Measured by venous blood sampling</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vascular function</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Duplex ultrasound system</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Height in cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Weight in kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Body mass in kilograms divided by height in meters squared</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Measured by automated sphygmomanometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic blood pressure</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Measured by automated sphygmomanometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Measured by 3-lead electrocardiogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiration</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Measured by spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical History Questionnaire</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Assesses inclusion/exclusion criteria and prior history of medical conditions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal Distress Questionnaire</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Measured using a 10 cm visual analogue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety Questionnaire</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Assessed with a visual analog scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive performance</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Computerized battery of neuropsychological tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise performance</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Step-wise exercise test on cycle ergometer</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Diet Modification</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sugar pill that will have no effect.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cannabidiol and herbal capsules (1 dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cannabidiol supplement with added ginseng, ginkgo biloba, and organic hemp oil.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cannabidiol (1 dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Only cannabidiol supplement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cannabidiol and herbal capsules (2 dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cannabidiol supplement with added ginseng, ginkgo biloba, and organic hemp oil.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cannabidiol only (2 dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Only cannabidiol supplement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cannabidiol supplement</intervention_name>
    <description>Subjects will be administered in a double-blinded, randomized and cross-over design</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Cannabidiol and herbal capsules (1 dose)</arm_group_label>
    <arm_group_label>Cannabidiol (1 dose)</arm_group_label>
    <arm_group_label>Cannabidiol and herbal capsules (2 dose)</arm_group_label>
    <arm_group_label>Cannabidiol only (2 dose)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  non-smoking

          -  non-obese

          -  between the ages of 18-30 &amp; 60-75 years

          -  have no history of cardiopulmonary, liver, gastrointestinal, kidney or cerebrovascular
             disease.

        Exclusion Criteria:

          -  are obese

          -  are taking prescription drugs or over-the-counter supplements that influence
             cardiovascular or nitric oxide metabolism

          -  have a history of smoking

          -  have history of cardiovascular, respiratory (including asthma) or neurological disease

          -  have known intolerance to ginseng or ginkgo herbals

          -  have kidney, gastrointestinal or liver disease

          -  have epilepsy

          -  have diabetes

          -  are pregnant or breast feeding

          -  do not speak English as first language

          -  a student in the University of British Columbia (UBC) Okanagan Centre for Heart, Lung
             and Vascular Health

          -  medical or recreational use of cannabis

          -  clinically diagnosed anxiety or depression

          -  history of opioid use

          -  unwilling or unable to execute the informed consent documentation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Philip Ainslie, PhD</last_name>
    <phone>2508786171</phone>
    <email>philip.ainslie@ubc.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexander Patrician, MSc</last_name>
    <phone>4168445954</phone>
    <email>alexander.patrician@alumni.ubc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of British Columbia</name>
      <address>
        <city>Kelowna</city>
        <state>Ontario</state>
        <zip>V1V 1V7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philip Ainslie, PhD</last_name>
      <phone>2508786171</phone>
      <email>philip.ainslie@ubc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Alexander Patrician, MSc</last_name>
      <phone>4168445954</phone>
      <email>alexander.patrician@alumni.ubc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Philip Ainslie, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2017</study_first_submitted>
  <study_first_submitted_qc>September 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2017</study_first_posted>
  <last_update_submitted>September 22, 2017</last_update_submitted>
  <last_update_submitted_qc>September 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Phil Ainslie</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>Vascular function</keyword>
  <keyword>Cannabidiol supplementation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual values will be reported in figures if applicable.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

